SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating 2seventy bio, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - March 11, 2025) - Rigrodsky Law, P.A. is investigating 2seventy bio, Inc. ("2seventy") (NASDAQ: TSVT) regarding possible breaches of fiduciary duties and other violations of law related to 2seventy's agreement to be acquired by Bristol Myers Squibb. Under the terms of the agreement, 2seventy shareholders will receive $5.00 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-2seventy-bio-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244221

You May Also Be Interested In

• F4 Mobile MT Strengthens Geophysical Targeting at Wales Lake
• Guggenheim Downgrades Alumis Inc (ALMS) to Neutral
• DelphX closes C$52,500 private placement, updates on CRS platform